Mutations of the MTHFR gene (428C>T and [458G>T+459C>T]) markedly decrease MTHFR enzyme activity

被引:14
|
作者
Yano, H [1 ]
Nakaso, K [1 ]
Yasui, K [1 ]
Wakutani, Y [1 ]
Nakayasu, H [1 ]
Kowa, H [1 ]
Adachi, Y [1 ]
Nakashima, K [1 ]
机构
[1] Tottori Univ, Fac Med, Inst Neurol Sci, Dept Neurol, Yonago, Tottori 6838504, Japan
关键词
methylenetetrahydrofolate reductase; MTHFR; mutations; enzyme activity;
D O I
10.1007/s10048-004-0177-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Methylenetetrahydrofolate reductase (MTHFR) is the only route for the synthesis of 5-methyltetrahydrofolate, which is utilized to convert homocysteine to methionine. In this study, we measured the enzyme activity of a mutant MTHFR that was detected in a patient with hyperhomocysteinemia. The 428C>T mutation in exon 2 of the MTHFR gene is a novel mutation, while the [458G>T+459C>T] mutation in exon 2 is a previously reported mutation. The activity of mutant enzymes containing the 428C>T, [458G>T+459C>T] and 677C>T mutations was 12.7+/-4.7%, 48.1+/-18.8%, and 43.6+/-14.4%, respectively, of that of the wild type enzyme. Our results suggest that these two variants each result in a severe MTHFR deficiency, which causes a developmental delay and cerebral vascular disease.
引用
收藏
页码:135 / 140
页数:6
相关论文
共 50 条
  • [31] 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis
    Kurzawski, Mateusz
    Pawlik, Andrzej
    Safranow, Krzysztof
    Herczynska, Magdalena
    Drozdzik, Marek
    PHARMACOGENOMICS, 2007, 8 (11) : 1551 - 1559
  • [32] MTHFR 677C>T polymorphism, migraine, and cardiovascular disease in women
    Schuerks, Markus
    Zee, Robert Y. L.
    Buring, Julie
    Kurth, Tobias
    NEUROLOGY, 2008, 70 (11) : A404 - A404
  • [33] Is there a role for the MTHFR 677C>T and 1298A>C polymorphisms in methotrexate-induced liver toxicity?
    te Loo, D. Maroeska W. M.
    Hagleitner, Melanie M.
    Coenen, Marieke J. H.
    PHARMACOGENOMICS, 2014, 15 (11) : 1401 - 1403
  • [34] MTHFR 677 C > T and 1298 A > C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer
    Reeves, Stuart G.
    Meldrum, Cliff
    Groombridge, Claire
    Spigelman, Allan D.
    Suchy, Janina
    Kurzawski, Grzegorz
    Lubinski, Jan
    McElduff, Patrick
    Scott, Rodney J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2009, 17 (05) : 629 - 635
  • [35] The role of 1691G>A (Leiden) mutation in Factor V gene, 20210G>A in prothrombin gene and 677C>T in MTHFR gene in etiology of early pregnancy loss
    Slezak, Ryszard
    Laczmanski, Lukasz
    Karpinski, Pawel
    Reszczynska-Slezak, Dorota
    GINEKOLOGIA POLSKA, 2011, 82 (06) : 446 - 450
  • [36] Methylenetetrahydrofolatereductase (MTHFR) 677C>T polymorphism and open angle glaucoma
    Mossbock, G
    Weger, M
    Faschinger, C
    Steinbrugger, I
    Temmel, W
    Schmut, O
    Renner, W
    Hufnagel, C
    Stanger, O
    MOLECULAR VISION, 2006, 12 (38-41): : 356 - 359
  • [37] An extensive meta-analysis of the association of MTHFR c.677C > T and c.1298A > C polymorphisms with gliomas
    El Idrissi, Hossam Hilal
    Boujmia, Oum kaltoum Ait
    Gazzaz, Bouchaib
    Tazzite, Amal
    Dehbi, Hind
    GENE REPORTS, 2021, 23
  • [38] MTHFR 677 C>T Gene Polymorphism is Associated with Large for Gestational Age Infants
    Akcilar, Raziye
    Yalinbas, Emine Esin
    Mutlu, Fezan
    FETAL AND PEDIATRIC PATHOLOGY, 2024, 43 (03) : 234 - 245
  • [39] Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C haplotypes:: New prognostic factors in chronic lymphocytic leukemia
    Nückel, H
    Frey, UH
    Dürig, J
    Dührsen, U
    Siffert, W
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R150 - R150
  • [40] Predictive value of 677C>T and 1298A>C polymorphisms of the methyletetrahydrofolate reductase (MTHFR) gene in patients treated with FOLFOX therapy
    Etienne-Grimaldi, M.
    Maindrault-Goebel, F.
    Chibaudel, B.
    Formento, J. L.
    Francoual, M.
    de Gramont, A.
    Lledo, G.
    Andre, T.
    Mabro, M.
    Milano, G. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)